1 / 1

pAMPK a (Thr 172 )

Control. Actiponin (300 mg/kg). pAMPK a (Thr 172 ). tAMPK a. Soleus m uscle. pACC (Ser 79 ). tACC. pAMPK a (Thr 172 ). tAMPK a. Liver. pACC (Ser 79 ). tACC.

osgood
Télécharger la présentation

pAMPK a (Thr 172 )

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Control Actiponin (300 mg/kg) pAMPKa (Thr172) tAMPKa Soleus muscle pACC (Ser79) tACC pAMPKa (Thr172) tAMPKa Liver pACC (Ser79) tACC Supplementary Fig. 1. Oral treatment with Actiponin increased AMPK and ACC phosphorylation in the soleus muscle and liver of mice. C57BL/6 male mice were treated with saline or Actiponin (300 mg/kg) for 9 days, and AMPK and ACC phosphorylation in the soleus muscle (60 mg protein) and liver tissues (80 mg protein) were analyzed by Western blot analyses

More Related